Patent · US Active

N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl

US7977355B2 · kind B2 · utility

0Cited by

11References

12Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Megan Murphy King · Wilmington, US
Cathy Dantzman · Wilmington, US
Glen Ernst · Bear, US
Thomas Hudzik · Wilmington, US
Khanh Bui · Wilmington, US

Key dates

Filing date	Dec 21, 2009
Grant date	Jul 12, 2011
Priority date	—
Expiry date	Jan 7, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, pharmaceutically acceptable salts thereof, and/or mixtures thereof, as well as, pharmaceutical compositions thereof, methods of treatment therewith, and processes of making N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and intermediates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.